U.S. Pharmaceuticals & Biotech Buy the Dip

Eli Lilly

Market Cap: US$1.0t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Bruker

Market Cap: US$9.8b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Krystal Biotech

Market Cap: US$9.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

TG Therapeutics

Market Cap: US$6.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Indivior Pharmaceuticals

Market Cap: US$4.4b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Veracyte

Market Cap: US$3.6b

Operates as a diagnostics company in the United States and internationally.

Arcutis Biotherapeutics

Market Cap: US$3.2b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Vera Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.

Fortrea Holdings

Market Cap: US$1.8b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Fortress Biotech

Market Cap: US$91.7m

Operates as a biopharmaceutical company in the United States and internationally.

Polyrizon

Market Cap: US$19.0m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

International Stem Cell

Market Cap: US$2.1m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.